Back to Search
Start Over
Therapy for insomnia with chronic obstructive pulmonary disease: a randomized trial of components.
- Source :
-
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine [J Clin Sleep Med] 2022 Dec 01; Vol. 18 (12), pp. 2763-2774. - Publication Year :
- 2022
-
Abstract
- Study Objectives: To determine efficacy and mechanisms of cognitive behavioral therapy for insomnia (CBT-I) and chronic obstructive pulmonary disease (COPD) education (COPD-ED) on clinical outcomes in adults with concurrent COPD and insomnia.<br />Methods: We conducted a 2 × 2 factorial study to test the impact of CBT-I and COPD-ED delivered alone or in combination on severity of insomnia and fatigue, sleep, and dyspnea. Participants were randomized to 1 of 4 groups-group 1: CBT-I + attention control (AC; health videos, n = 27); group 2: COPD-ED + AC, n = 28; group 3: CBT-I + COPD-ED, n = 27; and group 4, AC only, n = 27. Participants received six 75-minute weekly sessions. Dependent variables included insomnia severity, sleep by actigraphy, fatigue, and dyspnea measured at baseline, immediately postintervention, and at 3 months postintervention. Presumed mediators of intervention effects included beliefs and attitudes about sleep, self-efficacy for sleep and COPD, and emotional function.<br />Results: COPD patients (percent predicted forced expiratory volume in 1 second [FEV1pp] 67% ± 24% [mean ± standard deviation]), aged 65 ± 8 years, with insomnia participated in the study. Insomnia and sleep improved more in patients who received CBT-I than in those who did not, an effect that was sustained at 3 months postintervention and mediated by beliefs and attitudes about sleep. CBT-I was associated with clinically important improvements in fatigue and dyspnea. When CBT-I and COPD-ED were concurrently administered, effects on insomnia, fatigue, and dyspnea were attenuated.<br />Conclusions: CBT-I produced significant and sustained decreases in insomnia improved sleep and clinically important improvement in fatigue, and dyspnea. The combination of CBT-I and COPD-ED reduced CBT-I's effectiveness. Further research is needed to understand the mechanisms associated with effects of insomnia therapy on multiple symptoms in COPD.<br />Clinical Trial Registration: Registry: ClinicalTrials.gov; Name: A Behavioral Therapy for Insomnia Co-existing with COPD; URL: https://clinicaltrials.gov/ct2/show/NCT01973647; Identifier: NCT01973647.<br />Citation: Kapella M, Steffen A, Prasad B, et al. Therapy for insomnia with chronic obstructive pulmonary disease: a randomized trial of components. J Clin Sleep Med . 2022;18(12):2763-2774.<br /> (© 2022 American Academy of Sleep Medicine.)
- Subjects :
- Adult
Humans
Fatigue complications
Dyspnea complications
Dyspnea therapy
Treatment Outcome
Sleep Initiation and Maintenance Disorders complications
Sleep Initiation and Maintenance Disorders therapy
Cognitive Behavioral Therapy
Pulmonary Disease, Chronic Obstructive complications
Pulmonary Disease, Chronic Obstructive therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1550-9397
- Volume :
- 18
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 35946416
- Full Text :
- https://doi.org/10.5664/jcsm.10210